Akintunde (Tunde) Bello is a biopharmaceutical executive with over 25 years of experience in drug development across companies like Bristol Myers Squibb, Pfizer, and Sanofi. He currently serves as a Principal Consultant at Metrum Research Group, holds a board seat at Xilio Therapeutics, and earned his PhD from Kings College London.
He is dedicated to mentorship and leadership within the biopharmaceutical field, serving on the board of the RCDII Charity and receiving recognition from the Aleto Foundation for his efforts. Colleagues describe him as a passionate scientist who is a major positive influence on their careers.
He has contributed to the development, approval, and lifecycle management of 15 different marketed drugs across multiple therapeutic areas.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.